De novo use of low-dose tacrolimus and sirolimus in liver transplantation

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 33; no. 1-2; p. 1341
Main Authors Peltekian, K., McAlister, V.C., Colohan, S., Gao, Z., Salazar, A.B., Bitter-Suermann, H., MacDonald, A.S.
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.02.2001
Elsevier Science
Subjects
Adolescent
Adult
Aged
Biological and medical sciences
Drug Therapy, Combination
Female
Follow-Up Studies
Graft Survival - drug effects
Graft Survival - physiology
Humans
Immunomodulators
Immunosuppressive Agents - administration & dosage
Liver Transplantation - mortality
Liver Transplantation - physiology
Liver, biliary tract, pancreas, portal circulation, spleen
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Sirolimus - administration & dosage
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the digestive system
Tacrolimus - administration & dosage
Human
Sirolimus
Digestive system
Low dose
Treatment efficiency
Liver
Transplantation
Homotransplantation
De novo
Prevention
Rejection
Chemotherapy
Treatment
Tacrolimus
Surgery
Graft
Immunosuppressive agent
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(00)02501-X